Pacific Biosciences of California

PacBio develops comprehensive solutions for scientists that propel the field of genomics, improve science and research, and create positive impact globally. The Company provide sophisticated genomic analysis systems that deliver invaluable insights for scientists who strive to resolve complex genetic challenges.

TypePublic
HQMenlo Park, US
Founded2004
Size (employees)456 (est)+5%
Websitepacb.com
Pacific Biosciences of California was founded in 2004 and is headquartered in Menlo Park, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Pacific Biosciences of California Office Locations

Pacific Biosciences of California has offices in Menlo Park and Irvine
Menlo Park, (HQ)
1380 Willow Rd
Irvine,
4143 Health Sciences Rd
Show all (2)
Report incorrect company information

Pacific Biosciences of California Financials and Metrics

Pacific Biosciences of California Revenue

Embed Graph
View revenue for all periods
Pacific Biosciences of California's revenue was reported to be $93.47 m in FY, 2017
USD

Revenue (Q3, 2018)

18.2m

Gross profit (Q3, 2018)

3.2m

Gross profit margin (Q3, 2018), %

17.6%

Net income (Q3, 2018)

(25.0m)

EBIT (Q3, 2018)

(24.7m)

Market capitalization (4-Dec-2018)

1.1b

Closing stock price (4-Dec-2018)

7.7

Cash (30-Sep-2018)

38.1m
Pacific Biosciences of California's current market capitalization is $1.1 b.
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

28.2m60.6m92.8m90.7m93.5m

Revenue growth, %

115%53%(2%)

Cost of goods sold

21.8m37.2m39.3m46.6m58.8m

Gross profit

6.4m23.4m53.5m44.2m34.7m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

7.4m11.6m11.4m20.6m17.6m24.9m13.9m19.1m20.7m25.1m24.9m20.1m23.5m19.4m21.6m18.2m

Cost of goods sold

6.2m9.0m8.3m7.5m11.7m10.4m7.4m9.6m10.1m12.5m16.0m12.1m15.3m12.1m12.7m15.0m

Gross profit

1.2m2.7m3.1m13.2m5.9m14.5m6.6m9.5m10.6m12.6m8.9m8.0m8.2m7.3m8.9m3.2m

Gross profit Margin, %

17%23%27%64%34%58%47%50%51%50%36%40%35%38%41%18%
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

26.4m36.4m33.6m16.8m16.5m

Accounts Receivable

2.7m3.4m5.2m11.4m13.4m

Inventories

10.1m1.7m11.0m15.6m23.1m

Current Assets

126.5m117.8m110.5m109.0m101.6m
Quarterly
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

64.8m41.3m28.2m35.4m30.3m25.9m27.2m20.1m24.8m22.8m29.0m36.5m25.9m25.5m23.1m38.1m

Accounts Receivable

3.8m3.4m4.3m2.4m5.3m4.0m4.2m8.0m10.4m11.8m10.4m9.5m8.9m8.5m7.4m6.4m

Inventories

9.8m8.3m9.4m11.4m13.5m12.0m11.6m12.2m14.2m16.5m15.3m17.3m18.2m25.9m23.4m19.7m

Current Assets

141.8m132.1m119.9m114.1m99.5m90.2m86.2m119.1m138.1m122.5m88.3m132.9m113.6m115.7m96.4m143.9m
Annual
USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(79.3m)(66.2m)(31.7m)(74.4m)(92.2m)

Depreciation and Amortization

5.6m4.2m3.7m3.9m8.4m

Inventories

(60.0k)(1.3m)(2.5m)(6.2m)(8.4m)

Accounts Payable

(1.3m)3.9m(716.0k)3.4m764.0k
USDY, 2018

Financial Leverage

1.4 x
Show all financial metrics

Pacific Biosciences of California Operating Metrics

FY, 2016

Patents (Foreign)

133

Patents (US)

221

Patents Pending

187
Show all operating metrics

Pacific Biosciences of California Revenue Breakdown

Embed Graph

Pacific Biosciences of California revenue breakdown by geographic segment: 21.9% from Asia, 22.1% from Europe and 56.0% from North America

Report incorrect company information

Pacific Biosciences of California Online and Social Media Presence

Embed Graph
Report incorrect company information

Pacific Biosciences of California News and Updates

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Pacific Biosciences of California, Inc. - PACB

NEW YORK, Dec. 6, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating the Board of Directors of Pacific Biosciences of California, Inc....

Pacific Biosciences of California, Inc. Third Quarter 2018 Financial Results Call

MENLO PARK, Calif., Oct. 16, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its Third Quarter 2018 Financial Results on Thursday, November 1, 2018, at 4:30pm Eastern Time.

Pacific Biosciences of California, Inc. Announces Proposed Public Offering of Common Stock

MENLO PARK, Calif., Sept. 10, 2018 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering.  Pacific Biosciences also intends to grant the underwriters a 30-day option…
Report incorrect company information

Pacific Biosciences of California Blogs

Targeted PacBio Sequencing Adds to Scientific Arsenal in Evolutionary Arms Race

An international team of scientists from Arizona, India and Australia used targeted SMRT Sequencing to compare lab samples of pink bollworms with those collected from cotton fields to better understand Bt resistance within pest populations.

Barn Swallow Project Helps Introduce PacBio Long Read Technology to Italy

Its reliable return to the same spot year after year has made the barn swallow a beloved symbol of Spring and safe passage, for mariners and landlubbers alike. But our changing climate is altering the birds’ migratory behavior, and Italian ecologists are turning to genetics to figure out how. We spo…

Tracking the Tuna: How PacBio Sequencing Could Help Save the “King of the Sea”

In a recent webinar hosted by Nature, Stanford marine biologist Barbara Block joined PacBio scientist Paul Peluso to describe a project to protect Pacific and Atlantic bluefin tuna by assembling their genomes and transcriptomes.

At ASHG 2018, Workshop Speakers Discuss SMRT Sequencing Applications for Human Disease

Last month’s annual meeting of the American Society of Human Genetics in San Diego was a terrific reminder of how much progress is being made in this field, and a PacBio workshop attracted a standing room only audience. Find out what they learned from our scientists, as well as customers from Mount …

An Interview with Leslie Vosshall: Buzzing About the New Mosquito Reference Genome

How will the new mosquito reference genome change how we understand mosquito biology and its implications in viral transmission? Find out in this Q&A.

North American User Group Meeting: Highlights in Human, Animal, Insect, and Microbes

If you couldn’t attend our user group meeting, this recap will give you a sense of the highlights from the two-day meeting on Wash U’s campus.
Show more

Pacific Biosciences of California Company Life and Culture

Report incorrect company information

Pacific Biosciences of California Frequently Asked Questions

  • When was Pacific Biosciences of California founded?

    Pacific Biosciences of California was founded in 2004.

  • How many employees does Pacific Biosciences of California have?

    Pacific Biosciences of California has 456 employees.

  • What is Pacific Biosciences of California revenue?

    Latest Pacific Biosciences of California annual revenue is $93.5 m.

  • What is Pacific Biosciences of California revenue per employee?

    Latest Pacific Biosciences of California revenue per employee is $205 k.

  • Who are Pacific Biosciences of California competitors?

    Competitors of Pacific Biosciences of California include Oxford Nanopore Technologies, Medgate and RaySearch Laboratories.

  • Where is Pacific Biosciences of California headquarters?

    Pacific Biosciences of California headquarters is located at 1380 Willow Rd, Menlo Park.

  • Where are Pacific Biosciences of California offices?

    Pacific Biosciences of California has offices in Menlo Park and Irvine.

  • How many offices does Pacific Biosciences of California have?

    Pacific Biosciences of California has 2 offices.